Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, octobre 31
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Q32 Bio Inc
QTTB
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$8.91
0.04
0.45%
Dern. MÀJ: Oct 30, 4:38 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Q32 Bio Financials
Q32 Bio (QTTB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Q32 Bio Q2 EPS $(0.44) Beats $(0.54) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.54) by 18.52 percent. This is a 43.59 percent increase over losses of $(0.78) per share from the same
Benzinga Newsdesk
Stock Market Today: Dow Jones, Nasdaq 100, S&P 500 Futures Slips as US and Iran Exchange Strikes— Saratoga, Exxon Mobil, Levi's Strauss In Focus (UPDATED)
U.S. stock futures were mixed on Monday, as the Dow Jones index advanced, while the Nasdaq 100 and S&P 500 indices fell.
Rishabh Mishra
FB Financial, Smith Micro Software And 3 Stocks To Watch Heading Into Monday
U.S. stock futures down today, FB Financial, Smith Micro Software, LogProstyle, Veraxa Biotech, and Q32 Bio among stocks to watch. More premarket coverage at Benzinga.
Avi Kapoor
Earnings Scheduled For May 5, 2026
Benzinga Insights
PRO
Q32 Bio Q1 EPS $(0.54) Beats $(0.68) Estimate
Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.68) by 20.59 percent. This is a 40 percent increase over losses of $(0.90) per share from the same
Benzinga Newsdesk
PRO
Q32 Bio Q4 Adj. EPS $3.65 Beats $(0.98) Estimate, Sales $53.737M
Q32 Bio (NASDAQ:QTTB) reported quarterly earnings of $3.65 per share which beat the analyst consensus estimate of $(0.98) by 473.98 percent. This is a 414.66 percent increase over losses of $(1.16) per share from the
Benzinga Newsdesk
